497164-30-4

Basic information

• Product Name: Hydrazinecarboxylic acid, [[4-[(acetylamino)methyl]phenyl]methylene]-, 1,1-dimethylethyl ester, (2E)-
• CAS NO: 497164-30-4
• Molecular Formula: C15H21N3O3
• Molecular Weight: 291.35
• Mol File: 497164-30-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Hydrazinecarboxylic acid, [[4-[(acetylamino)methyl]phenyl]methylene]-, 1,1-dimethylethyl ester, (2E)-(CAS DataBase Reference)
• NIST Chemistry Reference: Hydrazinecarboxylic acid, [[4-[(acetylamino)methyl]phenyl]methylene]-, 1,1-dimethylethyl ester, (2E)-(497164-30-4)
• EPA Substance Registry System: Hydrazinecarboxylic acid, [[4-[(acetylamino)methyl]phenyl]methylene]-, 1,1-dimethylethyl ester, (2E)-(497164-30-4)

Safety Data

• Hazardous Substances Data: 497164-30-4(Hazardous Substances Data)

Upstream product

• 738615-92-4 N-(4-(1,3-dioxolan-2-yl)benzyl)acetamide 
• 104566-44-1 4-(1,3-dioxacyclopent-2-yl)benzylamine 
• 105-07-7 4-cyanobenzaldehyde 
• 66739-89-7 4-(1,3-dioxolan-2-yl)benzonitrile 
• 870-46-2 t-butoxycarbonylhydrazine 
• 156866-50-1 N-[(4-formylphenyl)methyl]acetamide 

Downstream Products

• 845725-39-5 1-{4-[(acetylamino)methyl]benzyl}-N-cycloheptyl-2-(2-naphthylsulfonyl)-1-hydrazinecarboxamide 
• 845725-37-3 N-(4-{[1-(azepanylcarbonyl)-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 
• 845725-35-1 N-(4-{[1-[(2-methyl-1-piperidinyl)carbonyl]-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 
• 845725-36-2 N-(4-{[2-(2-naphthylsulfonyl)-1-(1-piperidinylcarbonyl)hydrazino]methyl}benzyl)acetamide 
• 738615-56-0 N-(4-{[1-[(4-methyl-1-piperidinyl)carbonyl]-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 
• 845725-38-4 1-{4-[(acetylamino)methyl]benzyl}-N-cyclopentyl-2-(2-naphthylsulfonyl)-1-hydrazinecarboxamide 
• 738615-60-6 N-(4-{[1-(4-morpholinylcarbonyl)-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 
• 738615-64-0 1-{4-[(acetylamino)methyl]benzyl}-N-cyclopentyl-N-methyl-2-(2-naphthylsulfonyl)-1-hydrazinecarboxamide 

Relevant articles and documents

Novel non-covalent azaphenylalanine thrombin inhibitors with an aminomethyl or amino group at the P1 position

Design, synthesis and biological evaluation of a series of novel non-covalent azaphenylalanine thrombin inhibitors are presented. Replacement of the basic benzamidine moiety in azaphenylalanine derivatives by benzylamine (P1 part of a molecule) and the in